The Clorox Company $CLX Shares Bought by MAC Alpha Capital Management LP

Key Points

• MAC Alpha Capital Management increased its Clorox stake by 88.7% in the second quarter, bringing its holdings to 263,789 shares valued at approximately $25.2 million. Institutional investors collectively own 78.53% of the company.
• Clorox’s latest quarterly results exceeded expectations, with EPS of $1.66 and revenue of $1.95 billion, although revenue declined 2% year over year and EPS fell from $2.87.
• The company raised its quarterly dividend to $1.25 per share, representing a 6.0% annualized yield, while analysts remain cautious: the stock carries an average “Reduce” rating and a $101.40 price target.

MAC Alpha Capital Management LP lifted its stake in The Clorox Company (NYSE:CLX - Free Report) by 88.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 263,789 shares of the company's stock after acquiring an additional 124,019 shares during the period. Clorox makes up 5.0% of MAC Alpha Capital Management LP's portfolio, making the stock its 3rd largest holding. MAC Alpha Capital Management LP owned approximately 0.22% of Clorox worth $25,178,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Ancora Advisors LLC bought a new stake in Clorox in the 2nd quarter valued at $28,000. Avalon Trust Co bought a new position in shares of Clorox during the 2nd quarter worth about $29,000. Markowski Investments acquired a new position in shares of Clorox during the second quarter valued at about $30,000. Root Financial Partners LLC raised its position in shares of Clorox by 83.8% during the first quarter. Root Financial Partners LLC now owns 318 shares of the company's stock valued at $33,000 after buying an additional 145 shares during the last quarter. Finally, SHP Wealth Management bought a new stake in shares of Clorox in the fourth quarter valued at about $35,000. Institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

Clorox stock opened at $83.17 on Monday. The firm has a market capitalization of $10.06 billion, a P/E ratio of 17.26, a P/E/G ratio of 2.60 and a beta of 0.56. The stock has a fifty day moving average price of $98.27 and a two-hundred day moving average price of $98.93. The Clorox Company has a 52-week low of $83.09 and a 52-week high of $128.90. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The company had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the previous year, the company earned $2.87 EPS. The firm's revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, analysts anticipate that The Clorox Company will post 5.8 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th were given a dividend of $1.25 per share. The ex-dividend date was Wednesday, August 12th. This is an increase from Clorox's previous quarterly dividend of $1.24. This represents a $5.00 dividend on an annualized basis and a dividend yield of 6.0%. Clorox's dividend payout ratio is presently 103.73%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on CLX shares. UBS Group reissued a "neutral" rating on shares of Clorox in a research report on Friday, September 11th. Jefferies Financial Group cut Clorox from a "buy" rating to a "hold" rating and cut their price target for the company from $125.00 to $98.00 in a report on Tuesday, July 28th. BNP Paribas Exane decreased their price objective on Clorox from $97.00 to $95.00 and set a "neutral" rating on the stock in a report on Monday, July 20th. Citigroup lowered their price objective on Clorox from $100.00 to $97.00 and set a "neutral" rating on the stock in a research report on Friday, September 11th. Finally, Evercore set a $99.00 target price on Clorox in a research note on Tuesday, August 4th. Thirteen equities research analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Reduce" and an average price target of $101.40.

Clorox Profile

The Clorox Company NYSE: CLX is a consumer products company that develops, manufactures and markets household, health and wellness, and lifestyle products. Its portfolio includes cleaning and disinfecting products, laundry and home-care items, food products, personal-care products, water-filtration systems, charcoal, and cat litter.

Clorox's brands include Clorox bleach and disinfecting products, Pine-Sol, Fresh Step and Scoop Away, Kingsford, Brita, Burt's Bees, Hidden Valley, and products marketed under the Glad name.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.